Drugs / Soludomerin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02243436 Background | Nov 2014 → Jan 2019 | classic Hodgkin lymphoma | Spanish Lymphoma Cooperative Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soludomerin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02243436 ↗ |
| Route | Intravenous | “Intravenous use” NCT02243436 ↗ |